Jonathan Swift and Alzheimer's disease

Electrokinetic device design and constraints for use in high conductance solutions.

Electrophoresis·2017

Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort.

International journal of STD & AIDS·2015

Living and learning with managed care.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014

Physicochemical properties of ferumoxytol, a new intravenous iron preparation.

European journal of clinical investigation·2009

Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2008

Responses to hypoxia and recovery: repayment of oxygen debt is not associated with compensatory protein synthesis in the Amazonian cichlid, Astronotus ocellatus.

The Journal of experimental biology·2007

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

The past, present, and future of Alzheimer's disease-part 3: the future.

Arquivos de neuro-psiquiatria·2026

Impact of Antarctic radar on Southern Hemisphere atmospheric river reanalysis and forecast.

Scientific reports·2026

Acute retinal necrosis presenting exudative retinal detachment: a case report.

Frontiers in medicine·2026

Meteorological and Environmental Factors Associated With Sudden Cardiac Arrest During Marathons in Japan.

JACC. Advances·2026

Plasmonic nanocomposite helices for weather-adaptive LiDAR function.

Nature communications·2026

MicroRNAs in Aneurysmal Subarachnoid Hemorrhage: A Stage-Specific Model Linking Rupture, Vasospasm, and Outcome.

Biomedicines·2026

Related Experiment Videos

Jonathan Swift and Alzheimer's disease

Related Concept Videos

Electrokinetic device design and constraints for use in high conductance solutions.

Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort.

Living and learning with managed care.

Physicochemical properties of ferumoxytol, a new intravenous iron preparation.

Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Responses to hypoxia and recovery: repayment of oxygen debt is not associated with compensatory protein synthesis in the Amazonian cichlid, Astronotus ocellatus.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

The past, present, and future of Alzheimer's disease-part 3: the future.

Impact of Antarctic radar on Southern Hemisphere atmospheric river reanalysis and forecast.

Acute retinal necrosis presenting exudative retinal detachment: a case report.

Meteorological and Environmental Factors Associated With Sudden Cardiac Arrest During Marathons in Japan.

Plasmonic nanocomposite helices for weather-adaptive LiDAR function.

MicroRNAs in Aneurysmal Subarachnoid Hemorrhage: A Stage-Specific Model Linking Rupture, Vasospasm, and Outcome.

Related Experiment Videos

Jonathan Swift and Alzheimer's disease

Related Concept Videos

Related Articles